ソース:[1] Gilead Sciences, Inc. (GILD) Expands U.S. Manufacturing Capacity With $32B Investment Through 2030 (https://finance.yahoo.com/news/gilead-science ...)[2] Gilead Sciences' $32 Billion U.S. Expansion and Its Implications for Biopharma Innovation and Stock Value - AInvest (https://vertexaisearch.cloud.google.com/groun ...)[3] TRUMP EFFECT: A Running List of New U.S. Investment in President Trump's Second Term (https://vertexaisearch.cloud.google.com/groun ...)